Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT02876627 Completed - Cancer Clinical Trials

Effect Aerobic Training on Women With Breast Cancer After Chemotherapy

Start date: February 2015
Phase: Phase 1
Study type: Interventional

Introduction: The purpose of this study was to determine the effect of twelve weeks of aerobic exercise program on erythrocyte levels in women with breast cancer after chemotherapy. Methods: Thirty women with breast cancer after chemotherapy of Sydalshhda hospital (aged between 47-65 years) volunteered for this study, and then randomly selected an exercise (n = 15) and control (n = 15) groups. Exercise group completed a twelve-week aerobic exercise training program consisted of three sessions per week, each session lasting 30 to 60 minutes 50 to 75 percent of their maximum heart rate reserve, while the control group were followed. Blood samples including red blood cell counts (RBC), hematocrit (HCT), hemoglobin (HB), peak oxygen consumption before and after 12 weeks of aerobic exercise were measured. For analysis of data, repeated-measures analysis of variance (ANOVA) was used.

NCT ID: NCT02876510 Completed - Cancer Clinical Trials

ACTolog in Patients With Solid Cancers

ACTolog
Start date: June 30, 2017
Phase: Phase 1
Study type: Interventional

The study purpose is to learn about the safety and tolerability of IMA101 alone (Cohort 1) or in combination with atezolizumab (Cohort 2) in patients with advanced solid cancers that express pre-defined Immatics tumor targets.

NCT ID: NCT02874001 Completed - Cancer Clinical Trials

French Validation of an Interview Guide to Cancer Announcement : the Psycho Oncology Basic Documentation

PO-BADO
Start date: July 2015
Phase: N/A
Study type: Observational

Validation of the PO-BADO in its short and long versions that need a standardized validation process with the inclusion of 450 Patients

NCT ID: NCT02873923 Completed - Cancer Clinical Trials

Variability of Definitions for Survival Endpoints and Surrogate Properties for OS in Sarcoma Trials: a Meta-analysis

DATECAN-2
Start date: October 2012
Phase:
Study type: Observational

The DATECAN-2 project aims at assessing the surrogate properties for OS of several time-to-event endpoints through meta-analyses of completed and published randomized controlled trials. Two main cancer localization are concerned: breast cancer and soft-tissue sarcomas. The impact of survival endpoints' definitions on the trials' results and conclusions will also be evaluated.

NCT ID: NCT02873533 Completed - Cancer Clinical Trials

Modification of the Quality of Life Based on Objective Geriatric Tests

MEGERIA
Start date: March 2013
Phase: N/A
Study type: Interventional

The analysis of this study will achieve an improvement in the management of patients over 70 years with adaptation of chemotherapy regimens after analysis of the subject and its psychosocial environment. The analysis of socio-economic impacts will implement actions to optimize the care of the elderly while emphasizing the value of management / cost of care.

NCT ID: NCT02868112 Completed - Cancer Clinical Trials

Transdisciplinary Intervention Integrating Geriatric And Palliative Care With Oncology Care For Older Adults With Cancer

Start date: October 2016
Phase: N/A
Study type: Interventional

The purpose of this research study is to pilot test a transdisciplinary intervention that integrates both geriatrics and palliative care with routine oncology care for older adults with incurable cancer. The investigators will explore their perceptions of the supportive care needs of older patients with cancer. Using these data, the investigators will finalize the transdisciplinary intervention and perform a pilot, randomized trial of the transdisciplinary intervention versus usual care in patients age ≥65 with newly diagnosed, incurable cancer.

NCT ID: NCT02867462 Completed - Cancer Clinical Trials

Information Consultation by Radiotherapy Manipulator

INFORTH
Start date: April 2013
Phase: N/A
Study type: Interventional

The medical teams are increasingly sought by patients to get the most possible information, probably expressed in a different form and thereby supplementing the information already received. Coulter et al. reached similar conclusions in their study of the writings of patient information documents. They point out, moreover, the best adaptation of the patients better informed compared to those with less or no information. This need for information varies over time. It is present before treatment begins, continues during treatment and persists after treatment. Given the specific features of radiotherapy, the manipulators are important interlocutors to participate in the accompanying caregiver time. In conclusion, the quality of information delivered to the patient has been poorly evaluated, let alone with validated tools in this area. The impact of information on the tolerance of the treatment also needs to be confirmed, knowing that an informed patient seems less anxious and better prepared for future treatment.

NCT ID: NCT02867007 Completed - Cancer Clinical Trials

KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors

Start date: August 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to characterize the safety, tolerability, and determine the maximum tolerated dose (MTD) or the highest protocol-defined dose, in the absence of exceeding the MTD, of KHK2455 administered orally in combination with mogamulizumab to subjects with locally advanced or metastatic solid tumors.

NCT ID: NCT02866981 Completed - Cancer Clinical Trials

Observation for Patients With Asymptomatic CNS Metastatic Disease

Start date: February 2014
Phase: Phase 2
Study type: Interventional

The purpose of this registry is to determine if select patients with CNS metastatic disease can be safely observed rather than treated. The investigators hypothesize that there is a subset of patients with small asymptomatic CNS mets that do not require treatment, these patients can simply be observed and will not have CNS progression.

NCT ID: NCT02852473 Completed - Cancer Clinical Trials

Impact of Continuous Positive Airway Pressure on Breathing Motion Amplitude

Start date: July 2016
Phase: Phase 0
Study type: Interventional

This study involves a breathing motion assessment in healthy subjects before and after continuous positive airway pressure (CPAP) administration using MRI images. The hypothesis for this study is that CPAP administration will significantly reduce breathing motion. This may help cancer patients who are undergoing proton radiotherapy, so they possibly will not have to hold their breath during the procedure.